Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity

Eliciting effective antitumor immune responses in patients who fail checkpoint inhibitor therapy is a critical challenge in cancer immunotherapy, and in such patients, tumor-associated myeloid cells and macrophages (TAMs) are promising therapeutic targets. We demonstrate in an autochthonous, poorly...

Descripción completa

Detalles Bibliográficos
Autores principales: Perry, Curtis J., Muñoz-Rojas, Andrés R., Meeth, Katrina M., Kellman, Laura N., Amezquita, Robert A., Thakral, Durga, Du, Victor Y., Wang, Jake Xiao, Damsky, William, Kuhlmann, Alexandra L., Sher, Joel W., Bosenberg, Marcus, Miller-Jensen, Kathryn, Kaech, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839759/
https://www.ncbi.nlm.nih.gov/pubmed/29436395
http://dx.doi.org/10.1084/jem.20171435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839759/
https://www.ncbi.nlm.nih.gov/pubmed/29436395
http://dx.doi.org/10.1084/jem.20171435

Ejemplares similares